A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)

PHASE3CompletedINTERVENTIONAL
Enrollment

226

Participants

Timeline

Start Date

September 23, 2014

Primary Completion Date

March 9, 2016

Study Completion Date

March 9, 2016

Conditions
Early Breast Cancer
Interventions
BIOLOGICAL

PF-05280014

Concentrate for solution for infusion, sterile vial 150 mg, Day 1 Cycle 1 will be a loading dose of 8 mg/kg infused over 90 minutes. Subsequent infusions will follow every 3 weeks (i.e., cycled every 21 days) with a dose of 6 mg/kg administered over 30 to 90 minutes depending on tolerability, maximum of 6 cycles.

DRUG

Taxotere®

Injection concentrate single-dose vials containing 20 mg (0.5 mL) or 80 mg (2 mL), each mL contains 40 mg docetaxel (anhydrous) and 1040 mg polysorbate 80, The starting dose of Taxotere® (docetaxel) will be 75 mg/m2 administered intravenously over 60 minutes every three weeks on Day 1 of each cycle (i.e., every 21 days), maximum 6 cycles.

DRUG

Paraplatin®

Lyophilized powder, single-dose vials containing 50 mg, 150 mg, and 450 mg of Carboplatin for administration by intravenous infusion (each vial contains equal parts by weight of Carboplatin and mannitol), starting dose 6 AUC, over 15 minutes or longer every three weeks on Day 1 of each cycle (i.e., every 21 days), maximum 6 cycles.

BIOLOGICAL

Trastuzumab-EU

Concentrate for solution for infusion, sterile vial 150 mg, Day 1 Cycle 1 will be a loading dose of 8 mg/kg infused over 90 minutes. Subsequent infusions will follow every 3 weeks (i.e., cycled every 21 days) with a dose of 6 mg/kg administered over 30 to 90 minutes depending on tolerability, maximum 6 cycles.

DRUG

Taxotere®

Injection concentrate single-dose vials containing 20 mg (0.5 mL) or 80 mg (2 mL), each mL contains 40 mg docetaxel (anhydrous) and 1040 mg polysorbate 80, The starting dose of Taxotere® (docetaxel) will be 75 mg/m2 administered intravenously over 60 minutes every three weeks on Day 1 of each cycle (i.e., every 21 days), maximum 6 cycles.

DRUG

Paraplatin®

Lyophilized powder, single-dose vials containing 50 mg, 150 mg, and 450 mg of Carboplatin for administration by intravenous infusion (each vial contains equal parts by weight of Carboplatin and mannitol), starting dose 6 AUC, over 15 minutes or longer every three weeks on Day 1 of each cycle (i.e., every 21 days), maximum 6 cycles.

Trial Locations (52)

1083

Semmelweis Egyetem Altalanos Orvostudomanyi Kar-I. sz. Belgyogyaszati Klinika Onkologiai Reszleg, Budapest

1115

Szent Imre Egyetemi Oktato Korhaz, Budapest

1145

Uzsoki Utcai Korhaz, Onkoradiologia, Sugarterapia Fovarosi Onkoradiologiai Kozpont, Budapest

3526

Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktatokorhaz,, Miskolc

5000

Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz - Rendelointezet, Szolnok

6000

Bacs-Kiskun Megyei Korhaz, Kecskemét

11000

Institute For Oncology And Radiology Of Serbia, Belgrade

14029

Municipal Healthcare Institution 'Chernihiv Regional Oncology Dispensary', Mamology Department, Chernihiv

20141

Division of Medical Senology, Milan

21029

Vinnytsia Regional Oncology Clinical Dispensary, Chemotherapy Department, Vinnytsia

29009

Khmelnytskyi Regional Oncologic Dispensary, Khmelnytskyi

40005

"Regional Municipal Institution Sumy Regional Clinical Oncology Dispensary, Thoracic Department", Sumy

49102

MI 'City Dnipropetrovsk Multi-field Clin. Hospital #4 of DRC', Dep.-nt of Chemotherapy;, Dnipropetrovsk

50048

MI 'Kryvyi Rih Oncology Dispensary of Dnipropetrovsk Regional Council', Kryvyi Rih

61024

"SI Institute of Medical Radiology n.a.S.P. Hrygoriev of National Academy", Kharkiv

61070

"Munincipal Healthcare InstitutionKharkiv Regional Clinical Oncologic Center", Kharkiv

65025

Municipal Institution 'Odesa Regional Clinical Hospital', Mamology Center, Odesa

77339

Millennium Oncology (Imaging Facility), Kingwood

77380

Millennium Oncology (Imaging Facility), Shenandoah

77384

Millennium Oncology, Shenandoah

79031

Lviv State Oncologic Regional Treatment and Diagnostic Center, Lviv

92708

Compassionate Cancer Care Medical Group, Inc., Fountain Valley

115478

"FSBI Russian Oncology Scientific center n.a. N. N. Blokhin RAMS", Moscow

129301

State Budgetary Institution Of Healthcare, Moscow

173023

"SRBHI Regional Clinical Oncology Dispensary", Veliky Novgorod

188663

"State Budgetary Healthcare Institution Leningrad Regional Oncological Dispensary", Kuzmolovo

195067

"State Budgetary Educational Institution of Higher Professional Education North-Western State", Saint Petersburg

196247

Saint-Peterbsurg Clinical Oncological dispensary of Moscow district, Saint Petersburg

"Saint-Petersburg State Budgetary Healthcare Institution Oncological Dispensary of Moscow District", Saint Petersburg

197046

LLC RAMSAY Diagnostic RUS, Saint Petersburg

197758

"Federal State Institution Scientific Research Institute of Oncology n.a. N.N.Petrov", Saint Petersburg

198255

"Saint-Petersburg State Budgetary Institution of healthcare City Clinical Oncological Dispensary", Saint Petersburg

223040

SI 'Republican Research and Practice Centre of Oncology and Medical Radiology n.a. N.N. Alexandrov', Lyasny

305035

Regional Budgetary Healthcare Institution, Kursk

305524

"Regional Budgetary Healthcare Institution Kursk regional clinical oncological Dispensary", Kislino Settlement

357502

"State Budgetary Healthcare Institution of Stavropol Region Pyatigorsk Oncological Dispensary", Pyatigorsk

404130

"State Budgetary Healthcare Institution Volgograd Regional Oncological Dispensary #3", Volzhsky

450054

"State Budgetary Healthcare Institution Republican Clinical Oncological Dispensary of the Ministry", Ufa

603006

"SBHI of NNR Clinical diagnostic center", Nizhny Novgorod

603081

"State Budgetary Healthcare Institution of NNR Nizhniy Novgorod Regional Oncological Dispensary", Nizhny Novgorod

644046

"Budgetary Institution of healthcare of Omsk region Clinical oncological dispensary", Omsk

664035

"SBHI Regional Oncology Dispensary", Irkutsk

500 05

Fakultni nemocnice Hradec Kralove, Hradec Králové

00144

Divisione di Oncologia Medica B, Roma

IRCCS Istituto Nazionale Tumori Regina Elena (IRE), Roma

00168

Dept. of Surgery, Roma

81-519

Szpitale Wojewodzkie w Gdyni Sp. z o.o., Oddzial Onkoligii i Radioterapii, Gdynia

93-513

Oddzial Chorob Rozrostowych, Lodz

10-228

SPZOZ MSW z Warminsko-Mazurskim Centrum Onkologii w Olsztynie, Olsztyn

812 50

Onkologicky ustav sv. Alzbety, s.r.o., Bratislava

833 10

Narodny Onkologicky ustav, Bratislava

04191

Vychodoslovensky onkologicky ustav, a.s., Košice

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02187744 - A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04) | Biotech Hunter | Biotech Hunter